SE9404525D0 - New uses of indolo-(3,2-b)-quinoxalines - Google Patents
New uses of indolo-(3,2-b)-quinoxalinesInfo
- Publication number
- SE9404525D0 SE9404525D0 SE9404525A SE9404525A SE9404525D0 SE 9404525 D0 SE9404525 D0 SE 9404525D0 SE 9404525 A SE9404525 A SE 9404525A SE 9404525 A SE9404525 A SE 9404525A SE 9404525 D0 SE9404525 D0 SE 9404525D0
- Authority
- SE
- Sweden
- Prior art keywords
- indolo
- quinoxalines
- new uses
- phase
- oxidating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9404525A SE504862C2 (sv) | 1994-12-27 | 1994-12-27 | Användning av vissa indolo-§2,3b¤-kinoxaliner för framställning av ett läkemedel för skydd av DNA i initieringsfasen och/eller promotionsfasen av karcinogenes och för förhindrande av oxidativ stress i patienter med sjukdomar relaterade till fria radikaler |
ES95942370T ES2163536T3 (es) | 1994-12-27 | 1995-12-22 | Nuevas aplicaciones de las indolo-(2,3b)-quinoxalinas. |
JP8520413A JPH11501293A (ja) | 1994-12-27 | 1995-12-22 | インドロ−[2,3b]−キノキサリンの新規な用途 |
EP95942370A EP0799038B1 (en) | 1994-12-27 | 1995-12-22 | NEW USES OF INDOLO-[2,3b]-QUINOXALINES |
PCT/SE1995/001581 WO1996019996A1 (en) | 1994-12-27 | 1995-12-22 | NEW USES OF INDOLO-[2,3b]-QUINOXALINES |
AU43616/96A AU4361696A (en) | 1994-12-27 | 1995-12-22 | New uses of indolo-{2,3b}-quinoxalines |
DE69522582T DE69522582T2 (de) | 1994-12-27 | 1995-12-22 | NEUE VERWENDUNGEN VON INDOLO-[2,3b]-CHINOXALINEN |
US08/881,389 US6248742B1 (en) | 1994-12-27 | 1997-06-24 | Uses of indolo-(2,3b)-quinoxalines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9404525A SE504862C2 (sv) | 1994-12-27 | 1994-12-27 | Användning av vissa indolo-§2,3b¤-kinoxaliner för framställning av ett läkemedel för skydd av DNA i initieringsfasen och/eller promotionsfasen av karcinogenes och för förhindrande av oxidativ stress i patienter med sjukdomar relaterade till fria radikaler |
Publications (3)
Publication Number | Publication Date |
---|---|
SE9404525D0 true SE9404525D0 (sv) | 1994-12-27 |
SE9404525L SE9404525L (sv) | 1996-06-28 |
SE504862C2 SE504862C2 (sv) | 1997-05-20 |
Family
ID=20396484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9404525A SE504862C2 (sv) | 1994-12-27 | 1994-12-27 | Användning av vissa indolo-§2,3b¤-kinoxaliner för framställning av ett läkemedel för skydd av DNA i initieringsfasen och/eller promotionsfasen av karcinogenes och för förhindrande av oxidativ stress i patienter med sjukdomar relaterade till fria radikaler |
Country Status (8)
Country | Link |
---|---|
US (1) | US6248742B1 (sv) |
EP (1) | EP0799038B1 (sv) |
JP (1) | JPH11501293A (sv) |
AU (1) | AU4361696A (sv) |
DE (1) | DE69522582T2 (sv) |
ES (1) | ES2163536T3 (sv) |
SE (1) | SE504862C2 (sv) |
WO (1) | WO1996019996A1 (sv) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE504289C2 (sv) * | 1994-06-23 | 1996-12-23 | Leif J I Lundblad | Användning av vissa indolo-2,3b-kinoxaliner för framställning av ett läkemedel för inhibering av enzymet HIV-integras |
SE9704723D0 (sv) * | 1997-12-17 | 1997-12-17 | Leif J I Lundblad | Ligands |
SE516133C2 (sv) | 1999-02-25 | 2001-11-19 | Lundblad Leif J I | Användning av vissa substituerade indolokinoxaliner för framställning av ett medel för skydd av vävnader, organ och celler vid transplantation |
EP1064854A1 (en) * | 1999-06-15 | 2001-01-03 | Société des Produits Nestlé S.A. | Process for increasing the fruity taste of foodstuffs with acidified and/or fermented cereal flour |
SE527639C2 (sv) * | 2004-06-17 | 2006-05-02 | Oxypharma Ab | Alkylsubstituerade indolokinoxaliner |
US7863918B2 (en) * | 2007-11-13 | 2011-01-04 | International Business Machines Corporation | Disposable built-in self-test devices, systems and methods for testing three dimensional integrated circuits |
WO2022002898A1 (en) | 2020-06-29 | 2022-01-06 | Vironova Medical Ab | 6h-indolo(2,3-b)quinoxaline derivatives useful in therapy in particular in a virus infection |
US20230312578A1 (en) | 2020-06-29 | 2023-10-05 | Vironova Medical Ab | 6h-indolo[2,3-b]quinoxaline derivatives useful in therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8600260D0 (sv) * | 1986-01-21 | 1986-01-21 | Lundblad Leif | Substituerade indolokinoxaliner |
SE504289C2 (sv) * | 1994-06-23 | 1996-12-23 | Leif J I Lundblad | Användning av vissa indolo-2,3b-kinoxaliner för framställning av ett läkemedel för inhibering av enzymet HIV-integras |
-
1994
- 1994-12-27 SE SE9404525A patent/SE504862C2/sv not_active IP Right Cessation
-
1995
- 1995-12-22 ES ES95942370T patent/ES2163536T3/es not_active Expired - Lifetime
- 1995-12-22 DE DE69522582T patent/DE69522582T2/de not_active Expired - Fee Related
- 1995-12-22 WO PCT/SE1995/001581 patent/WO1996019996A1/en active IP Right Grant
- 1995-12-22 AU AU43616/96A patent/AU4361696A/en not_active Abandoned
- 1995-12-22 JP JP8520413A patent/JPH11501293A/ja active Pending
- 1995-12-22 EP EP95942370A patent/EP0799038B1/en not_active Expired - Lifetime
-
1997
- 1997-06-24 US US08/881,389 patent/US6248742B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69522582D1 (de) | 2001-10-11 |
WO1996019996A1 (en) | 1996-07-04 |
EP0799038A1 (en) | 1997-10-08 |
DE69522582T2 (de) | 2002-07-11 |
SE9404525L (sv) | 1996-06-28 |
ES2163536T3 (es) | 2002-02-01 |
AU4361696A (en) | 1996-07-19 |
SE504862C2 (sv) | 1997-05-20 |
JPH11501293A (ja) | 1999-02-02 |
US6248742B1 (en) | 2001-06-19 |
EP0799038B1 (en) | 2001-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS4073A (is) | Nýtt fjölvirknislyf gegn aukningu mótstöðu | |
DE60031396D1 (de) | Zubereitung zur behandlung von einer neurologischen erkrankung | |
PT797439E (pt) | Utilizacao de pramipexote como agente neuroprotector | |
BR9709823B1 (pt) | "compostos de amidas de ácido alqueno piridílico e alquino piridílico, métodos de preparação e uso dos mesmos, bem como medicamento". | |
CY2007001I2 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
NO924461D0 (no) | Dipyridamol for behandling av proliferaktive sykdommer | |
CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
EP0278174A3 (en) | Use of fluticasone propionate in the treatment of bowel diseases | |
IT1285770B1 (it) | Composti corticoidei | |
DE69824576D1 (de) | Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen | |
ES2184131T3 (es) | Derivados de benzamidina y su utilizacion como medicamentos con efecto antagonista de ltb4. | |
MX9704050A (es) | P-amidinobencilamidas de dipeptido novedosas con radicales sulfonilo o aminosulfonilo en terminal n. | |
DE69825440D1 (de) | VERWENDUNG VON TAUROLIDINE ZUR Herstellung eines Arzneimittels zur BEHANDLUNG VON LEUKÄMIEN | |
SE9404525D0 (sv) | New uses of indolo-(3,2-b)-quinoxalines | |
DE60013486D1 (de) | Verbindungen | |
IS5366A (is) | Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi | |
HUP0000523A2 (hu) | Éterlipid/kiegészítő alakú lipid kombinációt tartalmazó hordozók és terápiai alkalmazásuk | |
LV11940A (lv) | Melatonina pielietojums personu arstesanai kuras cies no zalu atkaribas | |
AU3684395A (en) | Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases | |
DE69738320D1 (de) | Verwendung von pyrolidin-derivaten zur herstellung von arzneimitteln zur behandlung von drogenmissbrauch | |
NO991581L (no) | N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler | |
NO913117L (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
NO990450L (no) | Behandling av sinnslidelser | |
DK0869785T3 (da) | 4-Hydroxycoumarin-3-carboxyamider til behandling af ikke-insulinafhængig diabetes mellitus | |
DE60043648D1 (de) | Medikamente zur behandlung von periodontalen erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |